Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled phase 2 study of amantadine in degenerative ataxias
2012-003315-63Phase 2Completed
- Sponsor
- FIBHULP
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Degenerative ataxia and Friedreich ataxia (FA) comparing amantadine with placebo (2 arms). Primary endpoint: Neurological assessment. Started Aug 2012; status: completed.
02
Drugs
amantadine
03
Conditions
Degenerative ataxiaFriedreich ataxia (FA)
Beyond the preview
Go deeper on 2012-003315-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003315-63.